POA Leadership

The Caris Precision Oncology Alliance™ (POA) Executive Committee establishes appropriate molecular testing principles to serve as guidelines for the consistent application of tumor profiling across the oncology community.

POA Leadership

Executive Committee
The Executive Committee facilitates collaborative research studies across the POA and coordinates outcome tracking initiatives to generate and document additional medical evidence for the appropriate use and impact of profiling. The Executive Committee of the POA serves as a resource to Caris leadership helping to drive research strategy and direction.

John L. Marshall, MD

Chief, Hematology and Oncology
Georgetown University

Elisabeth Heath, MD

Associate Center Director
Translational Sciences
Karmanos Cancer Institute

Heinz-Josef Lenz, MD, FACP

Associate Director for Clinical Research
USC Norris Comprehensive Cancer Center

Thomas Herzog, MD

Professor of OB-GYN
Deputy Director
University of Cincinnati Cancer Institute

Wafik El-Deiry, MD, PhD, FACP

Associate Dean for Oncologic Sciences
Brown University

Marcia Cruz-Correa, MD, PhD

Executive Director
University of Puerto Rico

Ruben Mesa, MD

President / Executive Director
Atrium Health
Levine Cancer / Wake Forest

Sagar Lonial, MD, FACP

Chief Medical Officer
Professor and Chair
Emory University

Joann Sweasy, PhD

Director, Cancer Center
Associate Director, Basic Sciences
University of Arizona

Manmeet Ahluwalia, MD, MBA

Chief, Solid Tumor Medical Oncology
Deputy Director, Chief Scientific Officer
Miami Cancer Institute

POA Members

A collaborative group leading cancer centers around the world

POA Publications

Contributing to the body of oncology research